Smith & Nephew (SNN) Current Deferred Revenue (2017 - 2025)
Smith & Nephew (SNN) posted quarterly Current Deferred Revenue of $114.0 million for Q4 2025, up 7.55% year-on-year from $106.0 million in Q4 2024, and up 7.55% on a QoQ basis from $106.0 million in Q4 2024.
Smith & Nephew (SNN) Current Deferred Revenue (2017 - 2025) Analysis & Trends
Smith & Nephew (SNN) has reported Current Deferred Revenue for 9 consecutive years, with $114.0 million the latest figure, recorded in Q4 2025.
- Quarterly Current Deferred Revenue rose 7.55% year-over-year to $114.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $114.0 million (up 7.55% YoY) and the FY2025 annual result came in at $114.0 million, up 7.55% from the prior year.
- Current Deferred Revenue advanced to $114.0 million in Q4 2025 per SNN's latest filing, from $106.0 million in the prior quarter.
- Over the last five years, Current Deferred Revenue for SNN reached as high as $114.0 million in Q4 2025 and fell as low as $92.0 million in Q4 2023.
- A 5-year average of $102.4 million and a median of $103.0 million in 2022 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2023 — Current Deferred Revenue decreased 10.68% — and 2024, when it increased 15.22%.
- Year by year, Current Deferred Revenue stood at $97.0 million in 2021, then grew by 6.19% to $103.0 million in 2022, then retreated by 10.68% to $92.0 million in 2023, then grew by 15.22% to $106.0 million in 2024, then gained by 7.55% to $114.0 million in 2025.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $114.0 million, $106.0 million, and $92.0 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 114.00 Mn |
| Dec 31, 2024 | 106.00 Mn |
| Dec 31, 2023 | 92.00 Mn |
| Dec 31, 2022 | 103.00 Mn |
| Dec 31, 2021 | 97.00 Mn |
| Dec 31, 2020 | 97.00 Mn |
| Dec 31, 2019 | 82.00 Mn |
| Dec 31, 2018 | 65.00 Mn |
| Dec 31, 2017 | 56.00 Mn |